MAPT and Alzheimer disease: To reduce subjectivity and potential influence of imaging and inflammation information on the final clinical diagnosis, in this study AD is defined biologically using the Paris-Lille-Montpellier (PLM) scale based on established thresholds for CSF measurements of Aβ42, Total Tau, and pTau [26–29].